Related Experiment Video
Updated: Aug 14, 2026
Germ Cell Transplantation and Testis Tissue Xenografting in Mice
Published on: February 6, 2012
Spermatogonial survival after grafting human testicular tissue to immunodeficient mice
Mieke Geens1, Gert De Block, Ellen Goossens
1Centre for Reproductive Medicine and Research Centre for Reproduction and Genetics, University Hospital and Medical School, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.
Background:
The xenografting of pre-pubertal human testicular tissue to an immunodeficient mouse is a theoretical strategy for restoring fertility in childhood cancer patients, while circumventing the risk of malignant recurrence. This study aimed at comparing the grafting of pre-pubertal and adult murine testicular tissue, as well as that of human adult testicular tissue, to two immunodeficient recipients, i.e. Swiss Nude mice and SCID-NOD mice.
Materials And Methods:
In this study, we evaluated the survival of pre-pubertal and adult murine testicular tissues, and that of adult human testicular tissue after subcutaneous grafting to immunodeficient mice.
Results:
After allografting pre-pubertal testicular tissue pieces, meiotic cells were observed in 69.1% of the grafts, while complete spermatogenesis was observed in 30.9%. All grafts of adult murine testicular tissue and 59.5% of the adult human testicular grafts showed sclerosis. However, in 21.6% of the adult human testicular grafts, spermatogonia were still observed, with increasing sclerosis in time. No significant differences were observed between the two mouse models under evaluation.
Conclusion:
After xenografting human adult testicular tissue to a recipient mouse, spermatogonia were maintained over a period of >195 days. However, in order to prove xenografting as a method for external germ line storage, the transplants should have a more immature developmental stage. Moreover, not only the developmental status of the tissue at the time-point of grafting, but also the structural organisation of the seminiferous epithelium, might influence the development of the testicular tissue.
Insights
Xenografting pre-pubertal human testicular tissue to mice shows promise for fertility restoration in childhood cancer survivors. While adult human grafts showed sclerosis, immature tissue is key for external germline storage.
Area of Science:
- Reproductive biology
- Cancer survivorship
- Transplantation immunology
Background:
- Xenografting testicular tissue offers a theoretical fertility restoration strategy for childhood cancer patients.
- This approach circumvents the risk of malignant recurrence associated with cancer treatments.
- Comparing pre-pubertal and adult murine, and adult human testicular tissue xenografting is crucial.
Purpose of the Study:
- To compare the survival and development of pre-pubertal and adult murine testicular tissue xenografts.
- To evaluate the survival and development of adult human testicular tissue xenografts.
- To assess the efficacy of two immunodeficient mouse models (Swiss Nude and SCID-NOD) as recipients.
Main Methods:
- Subcutaneous grafting of pre-pubertal and adult murine, and adult human testicular tissue into immunodeficient mice.
- Evaluation of graft survival and histological assessment for developmental stages and tissue integrity.
- Comparison of outcomes between Swiss Nude and SCID-NOD mouse recipients.
Main Results:
- Meiotic cells were observed in 69.1% of pre-pubertal testicular tissue grafts, with complete spermatogenesis in 30.9%.
- Adult murine and 59.5% of adult human testicular grafts exhibited sclerosis; however, spermatogonia persisted in 21.6% of adult human grafts.
- No significant differences in graft outcomes were noted between the Swiss Nude and SCID-NOD mouse models.
Conclusions:
- Spermatogonia were maintained for over 195 days in xenografted adult human testicular tissue.
- Immature testicular tissue is essential for successful external germline storage via xenografting.
- Both the developmental stage of the tissue and the seminiferous epithelium's structure influence xenograft outcomes.
